salvin has been researched along with arsenic trioxide in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, XL; Cong, WH; Guo, G; Li, H; Li, XX; Wang, R; Yu, XN | 1 |
| Hao, L; Lu-Qun, W; Ran, W; Xiang-Xin, L; Xiao-Ning, Y | 1 |
| Koike, S; Nishimoto, S; Ogasawara, Y; Suzuki, T; Takagi, N; Yuan, B | 1 |
3 other study(ies) available for salvin and arsenic trioxide
| Article | Year |
|---|---|
Synergism between carnosic acid and arsenic trioxide on induction of acute myeloid leukemia cell apoptosis is associated with modulation of PTEN/Akt signaling pathway.
Topics: Abietanes; Apoptosis; Arsenic Trioxide; Arsenicals; Base Sequence; Blotting, Western; Cell Cycle; DNA Primers; Drug Synergism; HL-60 Cells; Humans; Leukemia, Myeloid, Acute; Oxides; Plant Extracts; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction | 2012 |
Carnosic Acid-combined Arsenic Trioxide Antileukaemia Cells in the Establishment of NB4/SCID Mouse Model.
Topics: Abietanes; Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Caspase 3; Cell Line, Tumor; Disease Models, Animal; Drug Synergism; Female; Humans; Leukemia, Promyelocytic, Acute; Male; Mice; Mice, SCID; Oxides; PTEN Phosphohydrolase; RNA, Messenger | 2016 |
Nrf2 activation ameliorates cytotoxic effects of arsenic trioxide in acute promyelocytic leukemia cells through increased glutathione levels and arsenic efflux from cells.
Topics: Abietanes; Arsenic; Arsenic Trioxide; Arsenicals; Cell Line, Tumor; Cytotoxins; Glutathione; Humans; Leukemia, Promyelocytic, Acute; NF-E2-Related Factor 2; Oxides; RNA, Small Interfering | 2016 |